Smith & Nephew plc (LON:SN)
London
· Delayed Price · Currency is GBP · Price in GBp 983.60
-1.80 (-0.18%)
Apr 17, 2025, 5:27 PM BST
Smith & Nephew Revenue
In the year 2024, Smith & Nephew had annual revenue of $5.81B USD with 4.70% growth. Smith & Nephew had revenue of $2.98B in the half year ending December 31, 2024, with 14.07% growth.
Revenue
$5.81B
Revenue Growth
+4.70%
P/S Ratio
1.85
Revenue / Employee
$334.89K
Employees
17,349
Market Cap
8.61B GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 5.81B | 261.00M | 4.70% |
| Dec 31, 2023 | 5.55B | 334.00M | 6.40% |
| Dec 31, 2022 | 5.22B | 3.00M | 0.06% |
| Dec 31, 2021 | 5.21B | 652.00M | 14.30% |
| Dec 31, 2020 | 4.56B | -578.00M | -11.25% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.19B |
| GSK plc | 31.38B |
| Haleon | 11.23B |
| ConvaTec Group | 1.83B |
| Hikma Pharmaceuticals | 2.50B |
| HUTCHMED (China) | 503.39M |
| Oxford Nanopore Technologies | 183.19M |
| Genus | 671.60M |
Smith & Nephew News
- 15 days ago - Trump tariffs: these two European healthcare stocks face the highest US revenue exposure - Invezz
- 5 weeks ago - Smith+Nephew to showcase advanced Orthopaedic Reconstruction technologies for Robotics, Knees, Hips, and Shoulders at AAOS 2025 - GlobeNewsWire
- 5 weeks ago - Smith+Nephew to highlight breakthrough Sports Medicine technologies for joint repair at AAOS 2025 - GlobeNewsWire
- 6 weeks ago - Smith & Nephew PLC (SNN) Achieves Milestone in Hip Replacement Technology - GuruFocus
- 6 weeks ago - New report confirms Smith+Nephew's OXINIUM™ Technology is the best performing bearing surface at 20 years for total hip arthroplasty - GlobeNewsWire
- 6 weeks ago - Smith & Nephew gains after report it may evaluate a break-up - Seeking Alpha
- 6 weeks ago - Wound Care Market Size is Expected to Reach USD 32.75 Billion by 2033, Growing at a CAGR of 3.94%: Straits Research - GlobeNewsWire
- 7 weeks ago - MARKET REPORT: Recovery hopes breathe life into hip replacement maker Smith & Nephew - This is Money